Discovery and Optimization of Small-Molecule Ligands for the CBP/p300 Bromodomains
Small-molecule inhibitors that target bromodomains outside of the bromodomain and extra-terminal (BET) sub-family are lacking. Here, we describe highly potent and selective ligands for the bromodomain module of the human lysine acetyl transferase CBP/p300, developed from a series of 5-isoxazolyl-ben...
Hlavní autoři: | Hay, D, Fedorov, O, Martin, S, Singleton, D, Tallant, C, Wells, C, Picaud, S, Philpott, M, Monteiro, O, Rogers, C, Conway, S, Rooney, T, Tumber, A, Yapp, C, Filippakopoulos, P, Bunnage, M, Müller, S, Knapp, S, Schofield, C, Brennan, P |
---|---|
Médium: | Journal article |
Jazyk: | English |
Vydáno: |
American Chemical Society
2014
|
Podobné jednotky
-
Development of selective CBP/P300 benzoxazepine bromodomain inhibitors
Autor: Popp, T, a další
Vydáno: (2016) -
CBP30, a selective CBP/p300 bromodomain inhibitor, suppresses human Th17 responses.
Autor: Hammitzsch, A, a další
Vydáno: (2015) -
Generation of a Selective Small Molecule Inhibitor of the CBP/p300 Bromodomain for Leukemia Therapy
Autor: Picaud, S, a další
Vydáno: (2015) -
Chemical probes for bromodomains outside the BET family
Autor: Brennan, P, a další
Vydáno: (2013) -
The design and synthesis of 5-and 6-isoxazolylbenzimidazoles as selective inhibitors of the BET bromodomains
Autor: Hay, D, a další
Vydáno: (2013)